Implications of CD34+ Cell Dose on Clinical and Haematological Outcome of Allo-SCT for Acquired Aplastic Anaemia

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2009.267
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Clinical and Biological Predictors of Outcome Following Relapse of CML Post-Allo-SCT

Bone Marrow Transplantation
TransplantationHematology
2014English

High Frequency of Acquired Aplastic Anaemia in Tanzania

American Journal of Hematology
Hematology
2019English

Outcome of Allogeneic (Allo) Stem Cell Transplant (SCT) After Failure of a Prior SCT: A Single Center's Experience

Biology of Blood and Marrow Transplantation
TransplantationHematology
2009English

Advances in Understanding the Pathogenesis of Acquired Aplastic Anaemia

British Journal of Haematology
Hematology
2018English

Good Outcome of Haploidentical Hematopoietic SCT as a Salvage Therapy in Children and Adolescents With Acquired Severe Aplastic Anemia

Bone Marrow Transplantation
TransplantationHematology
2014English

Effect of Total Nucleated and CD34+ Cell Dose on Outcome After Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Aplastic Anaemia

Bone Marrow Transplantation
TransplantationHematology
2000English

Aplastic Anaemia

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1979English

Nutritional Anaemia: Clinical and Haematological Presentation in Children

International Journal of Contemporary Pediatrics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy